跳至主要内容
临床试验/PACTR201502001037220
PACTR201502001037220Other未知

[rVSV¿G-ZEBOV] Ebola Prevention Vaccine Evaluation in Sierra Leone

.S. Centers for Disease Control and Prevention0 个研究点目标入组 6,000 人开始时间: 2015年2月16日最近更新:

试验速览

阶段
未知
状态
Other
发起方
入组人数
6,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Year(s) 至 100 Year(s)(—)
性别
All

入选标准

  • 1.Age 18 years or older.
  • 2.Member of target population at time of enrollment:
  • -Active worker in an Ebola care, holding, or treatment center (may include physicians, nurses, nurse aides, lab technicians, pharmacists, pharmacy technicians, cleaners, and security and administrative staff);
  • -Active worker in a facility providing non-Ebola-related healthcare (may include physicians, nurses, nurse aides, lab technicians, pharmacists, pharmacy technicians, cleaners, and security and administrative staff);
  • -Active frontline worker in one of the following job categories: surveillance team, ambulance team, burial worker or worker responsible for swabbing deceased persons)
  • 3.Reasonably anticipates living in Sierra Leone for the 18-24 weeks following enrollment.
  • 4.Reachable by phone throughout the 6 month post-vaccination safety follow-up period.
  • 5.Willing to adhere to personal protective equipment (PPE) and infection control recommendations.
  • 6.Able and willing to complete the informed consent process and study procedures.
  • 7.Willing to receive vaccine in either the immediate or the deferred trial arms, according to random assignment.

排除标准

  • 1.History of Ebola (self-report).
  • 2.Prior receipt of experimental Ebola or Marburg vaccine.
  • 3.History of human immunodeficiency virus (HIV) or clinically important immunodeficiency (self-report).
  • 4.Any history of allergy or anaphylaxis to prior vaccines.
  • 5.Breast-feeding an infant or child.
  • 6.Any reason the investigator suspects that data collected from this person would be incomplete or of poor quality.
  • 7.Current pregnancy (a negative urine pregnancy test is required for women participants younger than 50 years of age who self report as not pregnant).
  • 8.Currently being followed for known exposure to Ebola.
  • 9.Known experimental research agents or other vaccine within 28 days (4 weeks) before vaccination.
  • 10.Fever greater than or equal to 38.0°C (greater than or equal to 100.4°F) at time of vaccination.

研究者

发起方
.S. Centers for Disease Control and Prevention

相似试验